Aims & Scope
Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.
The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.
The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
Ranking and Category
195th of 253 in Pharmacology & Pharmacy
Bentham Press Release — NEWS
- Most Accessed Article: Potential of Liposomes for Enhancement of Oral Drug Absorption
- Open Access Article: Pharmacogenetics of Intestinal Absorption
- New Issue Published Current Drug Delivery Vol. 14 Issue 5
- Call For Paper
- New Issue Published Current Drug Delivery Vol. 14 Issue 4
- Most Accessed Article:Tumor Thermal Ablation Enhancement by Micromaterials
- Open Access Article: “Temporal Separation in the Release of Bioactive Molecules from a Moldable Calcium Sulfate Bone Graft Substitute”
- Call For Paper
- Free Trial Request
- Most Accessed Article : Insights into Cellular Uptake of Nanoparticles
- Open Access Article: Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
- New Issue Published Current Drug Delivery Vol. 14 Issue 3
- Call For Paper
- Free Trial Request
- Open Access Article: Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
- Most Accessed Article: Insights into Cellular Uptake of Nanoparticles
- Call For Paper
- Free Trial Request
- Open Access Article: Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
- Issue Published Current Drug Delivery Vol. 14 Issue 2
- Issue Published Current Computer Aided-Drug Design Vol. 14 Issue 1
- Most Accessed Article: Identification of Novel Small-Molecule ASGP-R Ligands
- Free Online Issue Current Drug Delivery Vol. 14 Issue 1
- Call For Paper
- Free Trial Request
- Most Accessed Article: Application of Response Surface Methodology for Design and Optimization of Reservoir-type Transdermal Patch of Simvastatin
- Highlighted Article: Evaluation of Eudragit
Retard Polymers for the Microencapsulation of Alpha-Lipoic Acid - Most Cited Article: Paclitaxel Formulations: Challenges and Novel Delivery Options
- Most Accessed Article: Identification of Novel Small-Molecule ASGP-R Ligands
- Call For Paper
- Free Trial Request
- Podcast for (A podcast by Dr. John Slattery: Enteric Ecosystem Disruption in Autism Spectrum Disorder)
- Free Issue Online of Current Drug Delivery
- Highlighted Article: Hesperetin Liposomes for Cancer Therapy
- Free Trial Request
- Call For Paper
- Highlighted Article: Evaluation of Eudragit Retard Polymers for the Microencapsulation of Alpha-Lipoic Acid
- Most Cited Article: Prodrugs of Quercetin and Resveratrol: A Strategy Under Development
- Free Trial Offer
- Podcast on Self-Adjuvanting Therapeutic Peptide-Based Vaccine Induce
- Current Cancer Drug Delivery
- Free Online Trail
- Highlighted Article Flyer for the journal “Current Drug Delivery”
- Current Drug Delivery :::: New Issue
- Articles from Bentham Science Impact Factor Journal ‘Current Drug Delivery’
- Recently Published Issue of the Journal Current Drug Delivery
- New Issue ::: Current Drug Delivery , 13 Issue 6
- Major EPSRC Programme Grant to support new Oxford Centre for Drug Delivery Devices
- Lauren Sciences LLC independently recognized as a Leading Drug Delivery Company, and its V-Smart Platform selected as a Significant Advance in BBB Technology, by Datamonitor Healthcare
